<DOC>
	<DOCNO>NCT02348372</DOCNO>
	<brief_summary>GSK1278863A novel small molecule agent , stimulate erythropoiesis inhibition hypoxia-inducible factor ( HIF ) -prolyl hydroxylases ( EGLNs ) . This compound develop treatment anemia . This study , PHI115385 , first administration GSK1278863A Japanese subject investigate safety , tolerability , pharmacokinetics , pharmacodynamics single oral dos healthy Japanese adult subject . Healthy Caucasian adult subject include order compare pharmacokinetics GSK1278863A metabolite ( ) , pharmacodynamics GSK1278863A .</brief_summary>
	<brief_title>Study Evaluate Safety , Pharmacokinetics , Pharmacodynamics Single Oral Doses GSK1278863A Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Glycine</mesh_term>
	<criteria>AST , ALT , alkaline phosphatase bilirubin &gt; 1.5xULN . Healthy Male female 20 65 year age inclusive , time signing informed consent . Male subject female partner childbearing potential must agree use one contraception method . Body weight &gt; 50 kg BMI within range 18.5 29.0 kg/m2 ( inclusive ) . Capable give write informed consent . QTcB QTcF &lt; 450 msec ; QTc &lt; 480 msec subject Bundle Branch Block . Japanese define born Japan , four ethnic Japanese grandparent , hold Japanese passport identity paper able speak Japanese . Japanese subject also live outside Japan le 10 year . Caucasian , define individual four grandparent descendents original people Europe . A positive prestudy Hepatitis B surface antigen positive Hepatitis C antibody result within 3 month screen A positive prestudy drug screen . A minimum list drug screen include amphetamine , barbiturate , cocaine , opiates , cannabinoids benzodiazepines A hemoglobin value Screening : Healthy male subject postmenopausal female : &gt; 16.5 g/dL , Healthy female ( nonchildbearing potential ) subject : &gt; 15.5 g/dL The value hematological parameter screen : MCV : outside reference range deem clinically significant investigator GSK Medical Monitor . The value follow test Screening , healthy subject : TIBC : outside reference range population study , Serum iron : outside reference range population study , Serum ferritin : outside reference range population study A value screen great upper limit reference range follow clinical laboratory parameter : AST , ALT , direct bilirubin . Clinically significant abnormal CPK determine Investigator GSK Medical Monitor . Calculated creatinine clearance : &lt; 80 mL/min A positive test HIV antibody History drug abuse dependence within 6 month study . History regular alcohol consumption within 6 month study History regular use tobacco nicotinecontaining product within 6 month prior screen . Use prescription nonprescription drug , include vitamin , herbal dietary supplement ( include St John 's Wort ) within 7 day ( 14 day drug potential enzyme inducer ) 5 halflives ( whichever longer ) prior first dose study medication , unless opinion Investigator GSK Medical Monitor medication interfere study procedure compromise subject safety . By exception , subject may take acetaminophen ( &lt; 2 grams/day ) 48 hour prior first dose study drug . History sensitivity study medication , component thereof history drug allergy , opinion investigator GSK Medical Monitor , contraindicate participation . History sensitivity heparin heparininduced thrombocytopenia ( clinical research unit use heparin maintain intravenous cannula ) . Subjects preexist condition interfere normal gastrointestinal anatomy motility , and/or hepatic function could interfere absorption , metabolism , and/or excretion study drug . Examples condition could interfere normal gastrointestinal anatomy motility include cholecystectomy , gastrointestinal bypass surgery , partial total gastrectomy , small bowel resection , vagotomy , malabsorption , Crohn 's disease , ulcerative colitis , celiac sprue . Examples condition could interfere hepatic function include Gilberts syndrome . History peptic ulcer disease chronic rectal bleeding . History malignancy . Nonmelanoma skin cancer definitely remove allow . Subjects baseline medical history proliferative diabetic retinopathy , preproliferative diabetic retinopathy , wet agerelated macular degeneration ( AMD ) . Pregnant female determine positive serum urine hCG test screen prior dosing . Lactating female . Where participation study would result donation blood blood product excess 500 mL within 56 day period . Unwillingness inability follow procedure , lifestyle and/or dietary restriction outline protocol . Consumption &gt; 3 serving per day red wine , grapefruit ( juice ) , blood orange ( juice ) , star fruit , onion , kale , broccoli , green bean , apple 7 day prior first dose investigational product , unless opinion Investigator GSK Medical Monitor interfere study procedure compromise subject safety . The subject participate clinical trial receive investigational product within following time period prior first dose day current study : 30 day , 5 halflives twice duration biological effect investigational product ( whichever longer ) . Exposure four new chemical entity within 12 month prior first dose day . Subject mentally legally incapacitate .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>